Andrea Rappagliosi

 

Andrea is the Vice-President Public Affairs EMEA, Canada and LATAM at Edwards Lifesciences. the global leader in patient-focused innovations for structural heart disease and critical care monitoring

In his role, Andrea provides leadership and is accountable for the development and execution of
strategic Government Affairs, Market Access, Communication and Patients Advocacy programs to set a patient-centered innovation healthcare agenda across all European countries, MEA, Canada and Latin-America (EMEACLA). He is responsible to engage policymakers, governments, payers and HTA agencies across business units and the respective corporate functions. He is member of the regional Executive Leadership Team.

Andrea received a law degree from the University of Rome “La Sapienza”. Andrea began his professional career in the Italian Senate. Recently he worked in the Sanofi group as VP Public Affairs Europe and before as VP, Market Access, Health Policy and Medical Affairs at Sanofi Pasteur MSD. At SPMSD Joint Venture he was member of its Executive Committee from 2012 to 2016. Before, he worked at Baxter Healthcare, Serono International and GSK in different European and International positions in the public affairs and market access policy area.

In the last ten years, Andrea represented the healthcare Industry in several European EU Commission and Member States initiatives such as the HTANetwork, EUnetHTA Joint-Action 3, and the EU Active & Healthy Aging Innovation Partnership.  Andrea is a founding member of the HTAi Policy Forum. He was member of the High-Level Pharmaceutical Forum (2005-2008).